Large cardiovascular outcome trials involving tens of thousands of patientssuch as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide)have not demonstrated an increased incidence of medullary thyroid carcinoma or other thyroid malignancies compared to placebo groups
As a result, additional prospective and controlled studies are needed before definitive conclusions can be drawn
Research Resources Browse the Research Library and Research Guides for educational content on research compounds, testing, storage, and quality control
North Raleigh has evolved into one of the Triangles most sought-after residential corridors a mix of established neighborhoods, newer developments, and a thriving local economy that draws professionals and families from across the region
While data on tirzepatides long-term cardiovascular outcomes is still developing, early evidence points to comparable benefits, making both options valuable for patients looking to manage weight and enhance heart health simultaneously
Oxidative stress is caused by high levels of free radicals